POSB350 Real-World (RW) Patient-Reported Outcomes (PROs) in Frontline Maintenance Therapy for Advanced Non-Small Cell Lung Cancer (aNSCLC) in France, Germany, and the UK
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.1117
https://www.valueinhealthjournal.com/article/S1098-3015(21)02912-0/fulltext
Title :
POSB350 Real-World (RW) Patient-Reported Outcomes (PROs) in Frontline Maintenance Therapy for Advanced Non-Small Cell Lung Cancer (aNSCLC) in France, Germany, and the UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02912-0&doi=10.1016/j.jval.2021.11.1117
First page :
Section Title :
Open access? :
No
Section Order :
10650